Chemotherapy or radiotherapy is typically used to treat metastatic gastrointestinal tumors, while surgery is generally reserved for patients with complications.[19] The selection of systemic therapy depends on patient age, presenting symptoms, functional status, estrogen receptor status, and prior treatments. The gene discussed is ESR1; the disease is digestive system neoplasm.